Who Paid My Doc
Varian Ethos Treatment Planning
Device Oncology
PDI 00856100006141
General payments
$717,270
Research payments
$4,699,892
Through program year 2025, $717,270 in general payments and $4,699,892 in research payments were reported against Varian Ethos Treatment Planning (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $242,253 | 326 |
| 2025 | Research | $1,500,979 | 58 |
| 2024 | General | $175,293 | 287 |
| 2024 | Research | $1,206,003 | 54 |
| 2023 | General | $160,282 | 317 |
| 2023 | Research | $841,856 | 16 |
| 2022 | General | $57,098 | 107 |
| 2022 | Research | $954,429 | 16 |
| 2021 | General | $82,344 | 77 |
| 2021 | Research | $196,625 | 6 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 13 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 35 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,114 general · 150 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.